After a strong increase in the last 5 years, the gold price has weakened recently. Will demand for the precious metal increase again?
Erste Asset Management fund manager Anton Hauser, specialist for emerging markets bonds, analyses the status quo of the Turkish financial markets after the surprising dismissal of the Turkish central bank governor by President Erdogan.
US government bond yields have risen significantly in recent weeks. How does Erste Asset Management’s Head of Fixed Income Wolfgang Zemanek assess the interest rate development and the role of the central banks? Read more in the current blog interview on the bond markets.
Technologies – and, in particular, environmentally friendly ones – were THE big narrative on the stock exchanges last year. The upward trend of these companies continues in view of the clear political cues. Interview with Clemens Klein, Senior Professional Fund Manager.
A turbulent year at the stock exchange has come to a conciliatory end. Those who were invested in funds in 2020 were able to achieve increases in value despite the pandemic and lockdown. Read more about the best funds of 2020 in today’s blog.
These days a fund that has drawn the attention of many investors is celebrating its first birthday: the megatrend fund ERSTE FUTURE INVEST. The performance to date is respectable. Despite the corona pandemic, the fund has recorded comfortable gains, outperforming important stock exchange indices.
High-yield corporate bonds are currently in keen demand again, driven by the energetic steps taken by the central banks in their fight against the coronavirus crisis.
China has navigated the crisis quite well so far and that the growth rate of industrial production has picked up, too. All this in an environment where investors are looking for suitable investment opportunities. The Chinese bond market may just be what they are looking for.
Interview with fund manager Bernhard Selinger on the development of the fund ERSTE FUTURE INVEST.
The corona virus has a lock on the economy and the stock exchanges. Tests by the US pharmaceutical group Gilead in its search for a suitable remedy to fight the pandemic may be cause for hope. Harald Kober, senior fund manager of the equity fund ERSTE STOCK BIOTEC, keeps this company in the portfolio and has noticed a global increase in healthcare investments.